The Optimizer Smart and its successor, the Optimizer® Smart Mini, are minimally invasive, implantable devices that deliver a proprietary therapy to patients with heart failure. CCM® therapy is a unique treatment alternative for a specific population of heart failure patients. Both devices include an implantable stimulation device, which is similar in size to a pacemaker, and an external charging station. The device has a long battery life of 20 years.

The Optimizer Smart was one of the first cardiac devices to be granted Breakthrough Technology designation by the FDA. It received a unanimous positive vote on benefit-risk of the device, and ultimately received FDA approval in March of 2019. The Optimizer® Smart and Optimizer® Smart Mini are the only FDA-approved devices in the United States or elsewhere for the delivery of CCM® therapy. The device is intended to improve the lives of patients suffering from heart failure.

Facebook Page of the Product

Twitter Page of the Product

linkedin Page of the Product

Website of the Product